PriceTargets.com logo

Integer - ITGR Stock Price Target and Predictions

  • Consensus Rating: Buy
  • Consensus Price Target: $87.00
  • Forecasted Upside: 15.25%
  • Number of Analysts: 2
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 2 Buy Ratings
  • 0 Strong Buy Ratings
$75.49 As of 03/23/2023 01:00 AM ET
▲ +1.33 (1.79%)

This chart shows the closing price for ITGR by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Integer Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ITGR and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ITGR

Analyst Price Target is $87.00
▲ +15.25% Upside Potential
This price target is based on 2 analysts offering 12 month price targets for Integer in the last 3 months. The average price target is $87.00, with a high forecast of $90.00 and a low forecast of $85.00. The average price target represents a 15.25% upside from the last price of $75.49.

This chart shows the closing price for ITGR for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Buy

The current consensus among 2 investment analysts is to buy stock in Integer. This Buy consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/29/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/28/2021
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/28/2022
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/26/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/24/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/23/2022
  • 0 strong buy ratings
  • 1 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
2/21/2023
  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/23/2023

Latest Recommendations

  • 0 strong buy ratings
  • 2 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/24/2023Piper SandlerInitiated CoverageOverweight$85.00Low
2/9/2023KeyCorpBoost TargetOverweight$84.00 ➝ $86.00Low
11/1/2022BenchmarkLower Target$90.00Low
10/6/2022KeyCorpLower TargetOverweight$97.00 ➝ $84.00Low
7/29/2022KeyCorpLower TargetOverweight$109.00 ➝ $97.00Low
3/1/2022KeyCorpLower TargetOverweight$111.00 ➝ $109.00High
10/29/2021KeyCorpBoost TargetOverweight$107.00 ➝ $111.00High
9/13/2021ArgusBoost TargetBuy$100.00 ➝ $105.00Medium
7/30/2021KeyCorpBoost TargetOverweight$105.00 ➝ $107.00Medium
6/9/2021ArgusUpgradeHold ➝ Buy$100.00Low
10/30/2020KeyCorpLower TargetOverweight$87.00 ➝ $85.00High
10/7/2020ArgusDowngradeBuy ➝ HoldHigh
5/14/2020BenchmarkInitiated CoverageBuy$105.00Low
5/8/2020SidotiBoost TargetBuy$100.00 ➝ $108.00High
5/8/2020KeyCorpLower TargetOverweight$90.00 ➝ $87.00High
4/13/2020KeyCorpLower TargetOverweight$116.00 ➝ $90.00High
2/21/2020KeyCorpBoost TargetOverweight$97.00 ➝ $116.00Medium
8/2/2019Northcoast ResearchReiterated RatingBuyHigh
6/5/2019ArgusLower TargetBuy ➝ Average$90.00 ➝ $4.29Low
2/25/2019Royal Bank of CanadaBoost TargetSector Perform ➝ Sector Perform$84.00 ➝ $92.00Low
11/2/2018Royal Bank of CanadaBoost Target$84.00Low
11/2/2018KeyCorpBoost TargetOverweight ➝ Overweight$81.00 ➝ $93.00Low
8/3/2018Royal Bank of CanadaReiterated RatingHold$72.00High
7/20/2018Northcoast ResearchUpgradeBuy$83.00Low
7/13/2018Northcoast ResearchUpgradeNeutral ➝ BuyMedium
7/6/2018KeyCorpReiterated RatingOverweight ➝ Overweight$65.00 ➝ $78.00Medium
6/27/2018ArgusInitiated CoverageBuy$78.00Medium
5/4/2018KeyCorpBoost TargetOverweight ➝ Overweight$60.00 ➝ $62.00Low
(Data available from 3/23/2018 forward)

News Sentiment Rating

1.02 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 3 very positive mentions
  • 13 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
8/25/2022
  • 0 very positive mentions
  • 4 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
9/24/2022
  • 4 very positive mentions
  • 12 positive mentions
  • 4 negative mentions
  • 1 very negative mentions
Mentions as of
10/24/2022
  • 5 very positive mentions
  • 4 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/23/2022
  • 3 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/23/2022
  • 1 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/22/2023
  • 14 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/21/2023
  • 7 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
3/23/2023

Current Sentiment

  • 7 very positive mentions
  • 2 positive mentions
  • 1 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

Positive

Very Positive

Integer logo
Integer Holdings Corp. engages in the manufacture and development of medical devices and components. It operates through the Medical and Non-Medical segments. The Medical segment includes the cardio and vascular, cardiac and neuromodulation, surgical, orthopedics, and portable medical product lines. The Non-Medical segment comprises customized battery power and management systems, charging and docking stations, and power supplies. The company was founded by Wilson Greatbatch in 1970 and is headquartered in Plano, TX.
Read More

Today's Range

Now: $75.49
Low: $73.94
High: $76.28

50 Day Range

MA: $73.46
Low: $65.81
High: $77.00

52 Week Range

Now: $75.49
Low: $50.05
High: $88.58

Volume

402,351 shs

Average Volume

365,824 shs

Market Capitalization

$2.51 billion

P/E Ratio

38.13

Dividend Yield

N/A

Beta

1.11

Frequently Asked Questions

What sell-side analysts currently cover shares of Integer?

The following Wall Street research analysts have issued research reports on Integer in the last year: Benchmark Co., KeyCorp, Piper Sandler, StockNews.com, and TheStreet.
View the latest analyst ratings for ITGR.

What is the current price target for Integer?

3 Wall Street analysts have set twelve-month price targets for Integer in the last year. Their average twelve-month price target is $87.00, suggesting a possible upside of 15.2%. Benchmark Co. has the highest price target set, predicting ITGR will reach $90.00 in the next twelve months. Piper Sandler has the lowest price target set, forecasting a price of $85.00 for Integer in the next year.
View the latest price targets for ITGR.

What is the current consensus analyst rating for Integer?

Integer currently has 2 buy ratings from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe ITGR will outperform the market and that investors should add to their positions of Integer.
View the latest ratings for ITGR.

What other companies compete with Integer?

Other companies that are similar to Integer include Masimo, TransMedics Group, LivaNova, InMode and CONMED. Learn More about companies similar to Integer.

How do I contact Integer's investor relations team?

Integer's physical mailing address is 5830 Granite Parkway Suite 1150, Plano TX, 75024. The medical equipment provider's listed phone number is (214) 618-5243 and its investor relations email address is [email protected] The official website for Integer is www.integer.net. Learn More about contacing Integer investor relations.